Navigation Links
Prous Institute Presents Innovative Approach to Drug Discovery
Date:2/26/2009

BARCELONA, February 26 /PRNewswire/ -- Prous Institute for Biomedical Research today presented its strategies for drug discovery on its newly designed website (http://www.prousresearch.com). A large computational project with basic research support and broad disease coverage is being developed at Prous Institute under the broad-based Epistemic Drug Discovery(R) project.

President and C.E.O. of the Institute, Dr. J.R. Prous, explained that "We are committed to accelerating biomedical knowledge by the synchronization of powerful expert knowledge-based systems and basic research. This next-generation drug R&D force is expected to increase the efficiency and efficacy of core drug R&D processes, facilitating continuous innovation."

Two main drug discovery programs are being developed at the Institute. One is focused on the design, synthesis and biological evaluation of new small-molecule modulators of autophagy as therapeutic agents for cancer and neurodegeneration (Alzheimer's disease and Huntington's disease). Another program looks at target-driven drug discovery from natural sources, covering type 2 diabetes, psychological stress and asthma. The Institute's computational tools enable the in silico screening of thousands of natural products in a rapid, reliable and cost-effective manner, as well as the discovery of new targets and new uses for existing drugs.

J.R. Prous commented "our approach is bringing us closer to drug discovery, and the Institute expects to have several compounds in preclinical evaluation by the end of this year (2009)."

About Prous Institute for Biomedical Research

Prous Institute is a privately-held research-driven organization committed to the discovery and development of innovative therapies through the use of its powerful computational tools and the support of basic research. Prous Institute also fosters the development of prediction technologies used for regulatory and industry safety screening programs. Prous Institute receives several government grants and actively collaborates with academia and industry.

For more information, please contact Prous Institute: Xavier Mensa E-mail: info@prousresearch.com, Tel: +34-93-457-17-95, or visit http://www.prousresearch.com


'/>"/>
SOURCE Prous Institute for Biomedical Research, S.A.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
2. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
3. UKs Institute of Cancer Research and Silicon Graphics Establish Long-Term Alliance to Design and Outfit World-Class Network Biology Lab
4. American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows
5. Baltimore LASIK Surgeon Roy Chuck, MD, PhD of the Wilmer Eye Institute at Johns Hopkins Lists with Trusted LASIK Surgeons
6. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
7. IDRI Collaborates with the Brazilian Butantan Institute To Develop Novel Vaccines Against Leishmaniasis
8. National Cancer Institute: Battling Cancer and a Recession
9. The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
10. Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System
11. Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... SAN DIEGO and BEIJING ... Ltd., a leading commercial provider of genomic services and ... expertise, announced today that it has completed a USD ... China Merchants Bank Co., Ltd.,s CMB International Capital Management ... SDIC Innovation Investment Management Co., Ltd. ("SDIC Innovation") and ...
(Date:11/30/2016)... Mass. , Nov. 30, 2016   Merck ... that it has entered into a set of agreements ... services for Merck,s collection of genetic reagents such as ... with Evotec,s screening expertise offers an accelerated pathway to ... discovery starts with the identification of new targets, a ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... development of a new orally administered treatment for Alzheimer’s disease (AD), today announced ... a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s patients ...
(Date:11/30/2016)... ... November 30, 2016 , ... ProMIS Neurosciences (“ProMIS” or the ... diseases, today announced that all five of its validated monoclonal antibody (mAb) therapeutic ... toxic, prion-like forms of Amyloid beta (Aß) in vitro. , “We previously demonstrated ...
Breaking Biology Technology:
(Date:6/20/2016)... -- Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring announced that after exhaustive ... the final acceptance by all three (3) Department ... (MAS) installed. Furthermore, Securus will have contracts for ... October, 2016. MAS distinguishes between legitimate wireless device ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):